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ued until now.
Dexmedetomidine prolongs anesthesia and analgesia of local anesthetics in various neural blocks as
well as the onset of sensory and motor block. The objective of the present study was to evaluate
the effect of adding dexmedetomidine to local anesthetics on the sensory and motor block of the
subtenon block in patients undergoing phacoemulsiﬁcation cataract surgery.
Methods: Sixty patients of American Society of Anaesthesiologists (ASA) grade I–III, aged
between 18 and 70 years, scheduled for phacoemulsiﬁcation cataract surgery were randomly
assigned to two equal groups. Group C (control group) received 2 ml of a mixture of 2% lidocaine
and 0.5% bupivacaine and Group D (dexmedetomidine group) received 2 ml of a mixture of 2%
lidocaine and 0.5% bupivacaine plus dexmedetomidine (0.5 lg/kg). Onset and duration of sensory
and motor block was recorded. Pain during administration of anesthesia and during surgery
was graded using the verbal analogue scale and recorded. Intraocular pressure, hemodynamic,
and sedation parameters were recorded before and after surgery.
Results: Onset of both sensory and motor block was signiﬁcantly decreased in group D
(P< 0.001, P= 0.004 respectively), and duration of sensory and motor block was more prolonged
in group D than in group C (P< 0.001, P= 0.961). Pain during administration of anesthesia was
262 A.M. Eskandr et al.signiﬁcantly lower in group I compared with group II, and more patients in group I compared with
group II were pain free, without a signiﬁcant difference between the two groups. Intraocular pres-
sure was signiﬁcantly decreased in group D (P< 0.001). More sedation score was observed in
group D (P= 0.022). Heart rate and mean arterial blood pressure were insigniﬁcantly decreased
in group D more than in group C.
Conclusion: Dexmedetomidine is a safe and effective adjuvant to subtenon block in phacoemulsi-
ﬁcation cataract surgery.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license.1. Introduction
Dexmedetomidine is a novel selective a2 receptor agonist that
produces sedation and analgesia without causing respiratory
depression [1]. It also allows patients to respond to verbal com-
mands during the sedation; easy conversion from sleeping to
awakening is possible [2]. Therefore, dexmedetomidine has
been used in various clinical ﬁelds, such as sedation in the
intensive care unit, radiological examination of pediatric
patients, awake intubation, shockwave lithotripsy, endoscopic
examination [3–7] and an adjuvant to local anesthetics [8,9].
Many studies were done to evaluate its effect as sedative
when administered intravenously and other studies were done
to evaluate its effect on analgesia when added to local anesthe-
sia in axillary-supraclavicular and infraclavicular plexus, intra-
thecal, epidural and perineural block [10–16]. But no one, till
now studied its effect when used as adjuvant to local anesthet-
ics in subtenon block. So, the present study was scheduled to
study the effects of adding dexmedetomidine to local anesthet-
ics on the sensory and motor block of the subtenon block in
patients undergoing phacoemulsiﬁcation cataract surgery.2. Methods
After approval of the local ethical committee and obtaining
written informed consent, 60 patients, ASA grade I–III and
aged 18–70 years of both sex scheduled for elective phacoemul-
siﬁcation cataract surgery with sub-Tenon’s anesthesia were in-
cluded in this randomized blind study which was done in
Menouﬁya University Hospitals. Exclusion criteria included
the usual contraindications for regional anesthesia, coagula-
tion abnormalities, impaired mental status, uncontrolled glau-
coma, recent surgical procedure on the same eye, and refusal of
the patient. A peripheral intravenous catheter was inserted,
and monitoring included continuous electrocardiography,
pulse oximetry, and automated noninvasive blood pressure
measurement. Before induction of blockade, benoxinate
hydrochloride 0.4% drops were instilled and no IV sedative/
hypnotic medication was used before or during the block.
Patients were assigned randomly through closed envelop method
to receive single-injection. All punctures were performed by the
same person (anesthetist or surgeon) using a 25-gauge needle.
The needle was inserted to contact the conjunctiva between the
eyeball and the semilunaris fold, at a depth of less than 1 mm,
with the bevel directed toward the globe. The needle was then
shifted slightly medially, displacing the semilunaris fold and
caruncle away from the eyeball. The needle was advanced in
an anteroposterior direction, with the globe directed slightly
medially by the needle, until a ‘click’ was perceived, at a depth
of B15–20 mm. At this moment, the globe returned to the pri-mary gaze position. This point represents a reliable depth mar-
ker that conﬁrms the episcleral location of the tip of the needle.
In each group, the local anesthetic solution was injected after
an aspiration test, in group D (Dexmedetomidine group)
2 ml of a mixture of 0.5 lg/kg dexmedetomidine and equal
parts of 0.5% bupivacaine and 2.0% lidocaine was injected
and in group C (Control group) 2 ml of a mixture of equal
parts of 0.5% bupivacaine and 2.0% lidocaine was injected.
Demographic data included age, gender, weight, and height
were recorded. Duration of surgery, onset and duration of
sensory and motor block were recorded. Pain during anesthesia
administration and surgery was recorded. Patients rated pain
during injection of anesthetics and during surgery using the
verbal analog scale, with scores ranging from 0 to 4 (grade 0,
no pain; grade 1, mild pain; grade 2, moderate pain; grade 3,
severe pain; and grade 4, maximum pain). Also, hemodynamic
parameters (HR and MAP), sedation score and intraocular
pressure were recorded before and after surgery. Sensory block
duration or duration of analgesia was deﬁned as the time from
injection of local anesthetic mixture to complete recovery from
pain sensation or the ﬁrst need of rescue analgesia was mea-
sured and recorded. Motor block duration was described as
the time from injection of local anesthetic to complete recovery
of motor function in all ocular muscles. Ocular akinesia
(immobility) of the globe during surgery was scored. A 12-
point scale described by Brahma et al. [17] was used in which
akinesia of ocular movements in each quadrant was scored be-
tween 0 and 3 (0, no block; 1, partial akinesia unsuitable for
surgery; 2, partial but sufﬁcient akinesia; 3, total akinesia);
the ﬁnal score was the total of these four subscores; hence,
the minimum score possible was 0 and the maximum was 12
(3 · 4). The patient’s level of sedation was assessed using the
inverted observer’s assessment of alertness/sedation scale [18],
with a score of 1 = completely awake, 2 = awake but drowsy,
3 = asleep but responsive to verbal commands, 4 = asleep but
responsive to tactile stimulus, 5 = asleep and not responsive to
any stimuli.
There were no available previous data to depend on for cal-
culation of the sample size required in the present study so that
a pilot study was conducted on a number of 10 patients given
subtenon block and resulted in an increase in the duration of
the sensory block from 88.6 ± 4.79 min in the control group
to 181.1 ± 4.1 min in the group where dexmedetomidine was
added. The sample size was calculated to be 25 patients, so
we decided to include 30 patients in each group in the study.
We used GraphPad Stat Mate version 2 statistics program
for power analysis.
Statistical analysis was performed using SPSS version 10.
Results were expressed as the mean ± SD as indicated. A
Student’s t test was used to compare the quantitative variables
between the two groups. Chi-square analysis was used to
Table 1 Demographic data and duration of surgery.
Group D (n= 30) Group B (n= 30) P-value
Age (years) 57.97 ± 11.75 58.03 ± 11.41 0.984
Weight (kg) 74.6 ± 9.66 75.23 ± 7.54 0.779
Height (cm) 166.07 ± 5.64 166.03 ± 5.8 0.978
Sex (F/M) 10/20 12/18 0.789
Duration of surgery(min.) 26.2 ± 6.8 28.6 ± 5.62 0.142
Group C: control group, Group D: dexmedetomidine group, M: male, F: female, n= number of patients. Data were expressed as
mean ± standard deviation and number of patients.
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was considered signiﬁcant.
3. Results
There were no signiﬁcant differences between the two groups
with regard to age, weight, height, gender, and duration of sur-
gery (Table 1). As regards pain during administration of anes-
thesia, there was a signiﬁcant difference between both groups
for grades 0 and 1 (P< 0.05) and an insigniﬁcant difference
between the two groups for the other grades (Table 2). In addi-
tion, there was an insigniﬁcant difference between the studied
groups with respect to pain during surgery (Table 2) despite
more patients being pain free in dexmedetomidine group than
in control group during surgery. The onset of sensory block
was signiﬁcantly shorter in the dexmedetomidine group as
compared with the control group (P< 0.001). Also, the onset
of motor block (globe akinesia) was signiﬁcantly shorter in the
dexmedetomidine group than in the control group (P= 0.004)
(Table 3). As regards, the duration of analgesia or sensory
block (the time interval from injection of local anesthetic to
ﬁrst analgesic intake) was signiﬁcantly longer in the dexmede-
tomidine group as compared with the control group
(P< 0.001) (Table 3). There was no signiﬁcant difference
between the two groups (P= 0.961) as regards, the duration
of akinesia (Table 3). Akinesia score was better in dexmede-
tomidine group than in control group but with insigniﬁcant
difference between the two groups (Table 4). The intraocular
pressure showed a signiﬁcant decrease between the preopera-
tive and postoperative values in dexmedetomidine group and
between the two groups (P< 0.001) with insigniﬁcant differ-
ence in the control group (Table 5). The study showed more
signiﬁcant increase in numerical sedation score in the dex-
medetomidine group (P= 0.022) than in the control group
(Table 5). Mean arterial blood pressure was more decreasedTable 2 Pain during anesthesia and surgery.
Grade Pain during anesthesia
C group (n= 30) D group (n= 30)
0 20(66.7%) 28(93.3%)*
1 9(30%) 2(6.7%)*
2 1(3.3%) 0
3 0 0
4 0 0
Group C: control group, Group D: dexmedetomidine group, n= numbe
* P< 0.05: signiﬁcant.in the dexmedetomidine group than in the control group with
insigniﬁcant difference within and between them (Table 5). In
relation to heart rate, there was high signiﬁcant decrease in
dexmedetomidine group (P< 0.001) and insigniﬁcant differ-
ence in the control group between the preoperative and post-
operative measures with high signiﬁcant difference between
the two groups (P< 0.001) (Table 5).
4. Discussion
The present study demonstrated that adding dexmedetomidine
to lidocaine and bupivacaine mixture in subtenon block pro-
duces a signiﬁcant rapid onset of sensory and motor block, sig-
niﬁcant prolongation of analgesia and insigniﬁcant
prolongation of globe akinesia, and decreasing IOP with safe
hemodynamic changes and sedative effect.
Dexmedetomidine is a new alpha-2 agonist which has got
numerous beneﬁcial effects [14]. It acts on both pre- and
post-synaptic sympathetic nerve terminal and central nervous
system thereby decreasing the sympathetic outﬂow and norepi-
nephrine release causing sedative, anti-anxiety, analgesic, sym-
patholytic and hemodynamic effects [13,14]. Various clinical
studies on intravenous dexmedetomidine resulted in signiﬁcant
opioid sparing effects [6].
In previous animal studies, dexmedetomidine has been re-
ported to enhance sensory and motor blockade along with in-
creased duration of analgesia [7–10]. In humans,
dexmedetomidine has also shown to prolong the duration of
block and postoperative analgesia when added to local anes-
thetic in various regional blocks as axillary, supraclavicular
and infraclavicular brachial plexus, intrathecal, epidural and
perineural blocks [11–16]. These previous study results were
coincident with the present study results which showed signif-
icant decrease in onset of sensory and motor block with pro-
longation of sensory and motor block duration. These effectsPain during surgery
P-value C group D group P-value
0.024 27(90%) 29(96.7%) 0.612
0.045 2(6.7%) 1(3.3%) 1.000
1.000 1(3.3%) 0 1.000
– 0 0 –
– 0 0 –
r of patients. Data were expressed as number of patients (%).
Table 3 Onset and duration of sensory and motor block.
C group (n= 30) D group (n= 30) P-value
Onset of sensory block (min.) 2.43 ± 0.74 1.65 ± 0.63* <0.001
Onset of motor block (min.) 3.03 ± 1.35 2.1 ± 1.06* 0.004
Duration of sensory block (min.) 87.9 ± 4.9 182.6 ± 5.1* <0.001
Duration of motor block (min.) 159.73 ± 7.32 166.33 ± 5.94 0.961
Group C: control group, Group D: dexmedetomidine group, n= number of patients. Data were expressed as mean ± standard deviation.
* P< 0.05: signiﬁcant.
Table 4 Ocular movement during surgery.
Akinesia score C group (n= 30) D group (n= 30) P-value
0 1 (3.3%) 0 1.000
2 3 (10%) 1 (3.3%) 0.612
4 6 (20%) 7 (23.3) 1.000
6 6 (20%) 7 (23.3%) 1.000
8 12 (40%) 13 (43.4%) 1.000
10 2 (6.7%) 2 (6.7%) 1.000
12 0 0 –
Group C: control group, Group D: dexmedetomidine group,
n= number of patients. Data were expressed as number of patients
(%).
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ral actions. The central actions are mediated through a2
adrenoceptors, which are situated at locus coeruleus and
dorsal horn of spinal cord [19]. The peripheral actions of
dexmedetomidine on peripheral nerve blocks are mediated
through four mechanisms; these mechanisms are centrally
mediated analgesia, a2B adrenoceptor mediated vasoconstric-
tive effects, attenuation of inﬂammatory response and direct
action on peripheral nerve [20]. This direct action can be
explained on the basis of many studies, proposing that a2
agonists (clonidine, dexmedetomidine) by enhancing activity-
dependent hyperpolarization generated by the Na/K pump
during repetitive stimulation, increases the threshold for
initiating the action potential causing slowing or blockage of
conduction [21–23].
The intraocular hypotensive effect of dexmedetomidine in
the present study is consistent with previous several studies
on a2 agonists. Dexmedetomidine was effective in preventing
the rise of the IOP in response to succinylcholine and endotra-
cheal intubation [24]. Dexmedetomidine infusion as an adjunct
to local analgesia in ophthalmic surgery was effective in reduc-
tion in the IOP signiﬁcantly [25]. The drug was also found to
reduce the IOP by 34% after a single i.v. dose of dexmedetom-
idine 0.6 lg/kg [26]. Similar effects were shown in elderly pa-
tients during cataract surgery [27,28]. Also, Yazbeck-Karam
and co-workers studied supplementation of retrobulbar block
with clonidine in vitreoretinal surgery showed a decrease in
IOP [29]. On the contrary, when Lee and colleagues, infused
dexmedetomidine as a supplement to isoﬂurane anesthesia,Table 5 Intraocular pressure, sedation score and hemodynamic pa
C group (n= 30)
Intraocular pressure
Preoperative 16.17 ± 1.51
Postoperative 16.47 ± 1.46
P-value 0.437
Sedation score
Preoperative 1.07 ± 0.25
Postoperative 1.03 ± 0.18
P-value 0.561
Heart rate
C group D group P-valu
Hemodynamic parameters
Preop 74.73 ± 6.23 74.27 ± 6.14 0.77
Postop 74.47 ± 5.69 68.43 ± 3.89* <0.00
P-value 0.867 <0.001
Group C: control group, Group D: dexmedetomidine group, n = numbe
* P< 0.05: signiﬁcant.they found no IOP lowering effect [30]. This difference can
be explained as Lee and colleagues measured IOP at 3 times;
the base line, before the loading dose was given and 1 min after
intubation and the loading dose started 10 min before induc-
tion of anesthesia, as the time from the loading dose induction
till the last measurement was 10–11 min which is not a sufﬁ-
cient time for maximal effect of dexmedetomidine, while in
the present study, we compare between the baseline and the
postoperative measurement.
The effect of dexmedetomidine on the IOP may be caused
by a direct vasoconstrictor effect on the afferent blood vessels
of the ciliary body, which results in reduction in aqueous hu-
mor production [31]. Moreover, it could increase outﬂow oframeters.
D group (n= 30) P-value
16.1 ± 1.09 0.838
15.23 ± 0.57* <0.001
<0.001
1.07 ± 0.25 1.000
1.33 ± 0.55* 0.006
0.022
MAP
e C group D group P-value
4 93.03 ± 10.47 93.13 ± 10.99 0.971
1 91.07 ± 7.9 89.32 ± 6.66 0.357
0.416 0.11
r of patients. Data were expressed as mean ± standard deviation.
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cally mediated vasomotor tone of the ocular drainage system
[32]. Additionally, its associated hemodynamic response could
contribute to the IOP lowering effect [33].
Signiﬁcant decrease in heart rate and mean arterial blood
pressure from the baseline was reported in many studies, when
dexmedetomidine was added to local anesthetics [13–15,27,34].
The decrease in heart rate and mean arterial blood pressure
caused by a-2 agonist can be explained by their central action
decreasing the sympathetic outﬂow and norepinephrine re-
lease. Although the decrease in heart rate and mean arterial
blood pressure reported in dexmedetomidine group, it never
was less than 20% of the baseline values which proved that
the use a-2 agonists provides a hemodynamic stability during
the intra- and post-operative periods.
There was a signiﬁcant increase in sedation score in dex-
medetomidine group with arousable effects, which can be ex-
plained by the central action of dexmedetomidine as some
amount of systemic absorption of the drug could be present,
this is in accordance with other studies [11,19].
In conclusion, the present study demonstrated that adding
dexmedetomidine (0.5 lg/kg) to a mixture of 2% lidocaine
and 0.5% bupivacaine in subtenon block for patients undergo-
ing cataract phacoemulsiﬁcation surgery, resulted in a signiﬁ-
cant rapid onset and prolongation of analgesia and akinesia
with decreased IOP and stable hemodynamic changes. So, we
recommend more studies including large number of patients
to conﬁrm our study ﬁndings about the usage of dexmedetom-
idine as a safe and effective adjuvant to subtenon block.
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